Key stakeholders from The PATIENTS Program come together to celebrate past achievements and look towards future successes.

The Robert Wood Johnson Foundation’s Culture of Health Leaders program will provide Dr. Danya Qato with the tools to support her development as an agent of change for health equity and structural transformation.

Award from the Maryland Industrial Partnerships (MIPS) program supports work to formulate Clofazimine for treatment of recurrent C. difficile infections.

Inaugural event helps amplify the community’s voice and demonstrates the value of early engagement in research.

New center established by the School of Pharmacy, in collaboration with the University of Michigan, will increase access to safe and effective generic drugs through collaborative research, training, and exchange.

Meeting brings together 360 stakeholders from across academia, government, and industry to explore methods to develop better models that can identify and accurately predict drug risks and efficacy.

Information about the molecular shape of the viruses that cause COVID-19, SARS, and MERS reveals structural similarities that suggest possible drug treatments.

Virtual event brings together more than 500 attendees, including stakeholders from the FDA, academia, and industry.

Presentations from academic institutions and health care systems across the United States shared best practices and strategies to support the continued advancement of patient-centered outcomes research.

New non-invasive quality assurance method developed by Dr. Bruce Yu and his team offers more effective way to detect freezing events in vaccines at the point-of-care.

Peter Swaan, PhD, succeeds Paul Shapiro, PhD, as chair of the Department of Pharmaceutical Sciences at the University of Maryland School of Pharmacy.

Independent group will evaluate costs for certain new and existing medications and make recommendations about how to curb high drug prices.